Diagnosing Model Diagnostics
暂无分享,去创建一个
[1] France Mentré,et al. Metrics for External Model Evaluation with an Application to the Population Pharmacokinetics of Gliclazide , 2006, Pharmaceutical Research.
[2] Lewis B. Sheiner,et al. Estimation of population characteristics of pharmacokinetic parameters from routine clinical data , 1977, Journal of Pharmacokinetics and Biopharmaceutics.
[3] D. M. Grant,et al. The Art and Science of Personalized Medicine , 2007, Clinical pharmacology and therapeutics.
[4] Nicholas H. G. Holford,et al. The Visual Predictive Check Superiority to Standard Diagnostic (Rorschach) Plots , 2005 .
[5] S. Kweder,et al. Females in Clinical Studies: Where are We Going? , 2007, Clinical pharmacology and therapeutics.
[6] Mats O. Karlsson,et al. Assumption Testing in Population Pharmacokinetic Models: Illustrated with an Analysis of Moxonidine Data from Congestive Heart Failure Patients , 1998, Journal of Pharmacokinetics and Biopharmaceutics.
[7] L B Sheiner,et al. A Markov mixed effect regression model for drug compliance. , 1998, Statistics in medicine.
[8] Lewis B. Sheiner,et al. A Population Pharmacokinetic–Pharmacodynamic Analysis of Repeated Measures Time-to-Event Pharmacodynamic Responses: The Antiemetic Effect of Ondansetron , 1999, Journal of Pharmacokinetics and Biopharmaceutics.
[9] Z. Wiesenfeld‐Hallin,et al. Sex differences in pain perception. , 2005, Gender medicine.
[10] J. Stanford. The biology of human sex differences. , 2006, The New England journal of medicine.